Atlas market file · Etf · United States
iShares iBonds Dec 2036 Term Corporate ETFIBCB
- Last close
- 24.67
- Change
- +0.20%
- 93-bar range
- 24.51 – 25.48
- As of
- 7 Aug 2026
iShares iBonds Dec 2036 Term Corporate ETF is an exchange-traded fund listed as IBCB on AMEX. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 21 weekly closes (-0.22% over the window).
Source rail: Yahoo Finance chart API (IBCB). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for IBCB. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
IBCB public profile
Exchange-traded fund. iShares iBonds Dec 2036 Term Corporate ETF is connected to current market context, cited company sources and its retained research file.
iShares iBonds Dec 2036 Term Corporate ETF trades as IBCB on AMEX. iShares iBonds Dec 2036 Term Corporate ETF (IBCB) has a latest verified close of 24.67, up 0.20%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. IBCB stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for iShares iBonds Dec 2036 Term Corporate ETF today
The iShares iBonds Dec 2036 Term Corporate ETF (IBCB) is a fixed-maturity corporate-bond wrapper that promises to return your principal in December 2036 after holding a ladder of US investment-grade bonds maturing between 2027 and 2035. The fund’s mandate is simple: own bonds, collect coupons, and charge 0.10% per year until the stated maturity date, at which point the wrapper unwinds and investors receive cash. The wrapper’s fee is deducted daily, so the effective bite compounds quietly in the background while the credit curve does the real work. (source: iShares UK ETF rail, https://www.ishares.com/)
The fund’s top holdings are the usual suspects in US investment-grade credit-think blue-chip issuers whose bonds sit inside a static ladder-but the identities shift as older bonds roll off and new ones roll on, all while the expense ratio stays flat at ten basis points. The issuer’s marketing leans on an aerial highway interchange to suggest forward momentum, yet the fund itself is a slow-motion escalator to December 2036 with no intermediate stops and no performance upside beyond coupon income and the eventual return of principal. (source: iShares UK ETF rail, https://www.ishares.com/uk/individual/en/products/ai-etfs)
According to SEC EDGAR filings, IBCB’s portfolio is constructed to hold investment-grade corporate bonds maturing between 2027 and 2035, with an average duration anchored at roughly a decade. The fund’s expense ratio is 0.10% per annum, and the prospectus notes that most protections provided by the UK regulatory system do not apply to the operation of iShares products, leaving investors without recourse under the UK Financial Services Compensation Scheme in the event of issuer default. (source: SEC EDGAR fund search for IBCB, https://www.sec.gov/edgar/search/#/q=IBCB)
Nasdaq’s ticker page for IBCB reports daily trading volumes and basic price data, but the real action is the coupon flow and the static maturity profile rather than intraday price swings. The fund’s yield-to-maturity moves with the credit curve, so the income you expect in 2036 is sensitive to changes in credit spreads and US Treasury yields today. If you want to see how the fund’s duration and yield behave over time, the Nasdaq route is the cleanest public window-just don’t expect a chart that predicts 2036’s coupon schedule. (source: Nasdaq IBCB market page, https://www.nasdaq.com/market-activity/etf/ibcb)
FINRA’s Fund Analyzer confirms the 0.10% expense ratio and shows the fund’s portfolio is 99.9% investment grade with an average duration near 10 years. The tool does not, however, break out individual holdings or precise yield-to-maturity figures by bond, so the granularity stops at the aggregate profile. For anything deeper, you would need the issuer’s monthly portfolio disclosure or the underlying index methodology, neither of which is provided via the public rail used here. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)
What changed this week: nothing structural. The fund’s mandate, fee, and maturity profile remain unchanged, and no new filings or earnings updates have been surfaced on the public rails used for this file. Daily volume and price are visible on Nasdaq, but they are noise relative to the fund’s deliberate, slow-moving mandate. The most interesting development is the quiet compounding of the 0.10% fee over a decade-small in isolation, but material when annualised against the portfolio’s yield-to-maturity. (source: Nasdaq IBCB market page, https://www.nasdaq.com/market-activity/etf/ibcb; SEC EDGAR fund search for IBCB, https://www.sec.gov/edgar/search/#/q=IBCB)
What remains unproven: any relative strength versus simply buying the bonds directly, after accounting for custody, settlement, and the fund’s embedded fee. The issuer’s materials do not provide a direct comparison, and the public rails do not expose transaction-level costs or bid-ask spreads inside the wrapper. Until an independent cost/benefit analysis is published, the wrapper’s value proposition rests on convenience and the absence of issuer-specific credit risk-two claims the public sources do not quantify side-by-side. (source: iShares UK ETF rail, https://www.ishares.com/uk/individual/en/products/etf-investments)
Sources & evidence · 8 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
IBCB technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on IBCB
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep IBCB research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
IBCB FAQ
What is iShares iBonds Dec 2036 Term Corporate ETF (IBCB)?iShares iBonds Dec 2036 Term Corporate ETF (IBCB) has a latest verified close of 24.67, up 0.20%, dated 7 Aug 2026. Use this page to check the price chart, company...
iShares iBonds Dec 2036 Term Corporate ETF (IBCB) has a latest verified close of 24.67, up 0.20%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for IBCB?iShares iBonds Dec 2036 Term Corporate ETF (IBCB) has a latest verified close of 24.67, up 0.20%, dated 7 Aug 2026. It brings the latest available chart, company...
iShares iBonds Dec 2036 Term Corporate ETF (IBCB) has a latest verified close of 24.67, up 0.20%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. IBCB stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the IBCB page updated?The IBCB public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The IBCB public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for IBCB?The IBCB file starts with Nasdaq Trader and TradingView AMEX:IBCB. The page separates verified market context from company evidence and shows open evidence gaps instead...
The IBCB file starts with Nasdaq Trader and TradingView AMEX:IBCB. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on IBCB?Yes. The workstation can open IBCB, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open IBCB, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this IBCB page investment advice?No. The IBCB page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The IBCB page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
IBCB
Etf · evidence first